...
首页> 外文期刊>Investigative ophthalmology & visual science >Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease
【24h】

Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease

机译:自动化的泪膜表面质量破坏时间作为干眼病中泪液高渗的新临床标志

获取原文
           

摘要

Purpose: To assess the diagnostic performance of a novel, automated, noninvasive measure of tear film stability derived from Placido disc videokeratography, the tear film surface quality breakup time (TFSQ-BUT), as a clinical marker for diagnosing dry eye disease (DED) relative to a standard of tear hyperosmolarity. Methods: This prospective, cross-sectional study involved 45 participants (28 DED, 17 controls). Symptoms (Ocular Surface Disease Index) and signs (tear osmolarity, TFSQ-BUT, tear breakup time measured with sodium fluorescein [NaFl-BUT], ocular surface staining and Schirmer test with topical anesthesia) of DED were assessed. Three measures of TFSQ-BUT and NaFl-BUT were taken per eye; a??first,a?? a??average,a?? and a??shortesta?? BUT were analyzed separately. Optimal diagnostic cutoff values were determined using the Youden Index. The repeatability and agreement of the TFSQ-BUT was compared with two clinicians who manually assessed noninvasive BUT (CNI-BUT). Repeatability of methods was assessed using the geometric coefficient of variation (gCoV, %). Agreement between methods was considered with Bland-Altman analysis. Results: Eyes with DED had significantly shorter TFSQ-BUTs than controls (P 0.05). There was a significant, moderate correlation between both shortest and average TFSQ-BUT and NaFl-BUT (r = 0.35, P = 0.02 and r = 0.38, P = 0.01, respectively). The receiver-operator characteristic (ROC) curve for shortest TFSQ-BUT showed an area under the curve of 0.92 (P 0.0001). Shortest TFSQ-BUT with a criterion of 12.1 seconds had a sensitivity of 82% and specificity of 94% for diagnosing DED against tear hyperosmolarity. Automated TFSQ-BUT showed less variability (gCoV = 9.4%, 95% confidence interval [CI]: 7.1%a??14.0%) than CNI-BUT (gCoV = 27.0%, 95% CI: 19.62%a??41.06%, P 0.05). Conclusions: Automated TFSQ-BUT is a repeatable, noninvasive clinical marker with both high sensitivity and specificity for tear hyperosmolarity.
机译:目的:评估源自Placido光盘角膜塑形术的新型自动化,无创性泪膜稳定性测量方法的诊断性能,即泪膜表面质量破坏时间(TFSQ-BUT),作为诊断干眼病(DED)的临床指标相对于泪液渗透压的标准。方法:这项前瞻性,横断面研究涉及45名参与者(28名DED,17名对照)。评估DED的症状(眼表疾病指数)和体征(眼渗透压,TFSQ-BUT,用荧光素钠[NaFl-BUT]测量的眼泪破裂时间,眼表染色和局部麻醉的Schirmer试验)。每只眼睛采取了TFSQ-BUT和NaFl-BUT三种测量方法;一个?首先,一个?平均?和一个“ shortesta”但是分别进行了分析。使用Youden Index确定最佳诊断临界值。将TFSQ-BUT的可重复性和一致性与手动评估无创BUT(CNI-BUT)的两名临床医生进行了比较。使用几何变异系数(gCoV,%)评估方法的可重复性。使用Bland-Altman分析考虑了方法之间的一致性。结果:DED眼的TFSQ-BUT明显短于对照组(P <0.05)。最短和平均TFSQ-BUT和NaF1-BUT之间存在显着,中等的相关性(分别为r = 0.35,P = 0.02和r = 0.38,P = 0.01)。最短的TFSQ-BUT的接收器-操作员特性(ROC)曲线显示曲线下的面积为0.92(P <0.0001)。最短的TFSQ-BUT(标准为12.1秒)对DED诊断泪液高渗性的敏感性为82%,特异性为94%。自动化TFSQ-BUT的变异性(gCoV = 9.4%,95%置信区间[CI]:7.1%a ?? 14.0%)比CNI-BUT(gCoV = 27.0%,95%CI:19.62%a ?? 41.06% ,P <0.05)。结论:自动化TFSQ-BUT是一种可重复的无创临床标志物,对泪液高渗性具有高敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号